Related Experiment Video
Updated: May 21, 2026
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Intravitreal bevacizumab for choroidal metastasis of lung carcinoma; a case report
Aída Sánchez de la Barquera Cordero1, Rene Alfredo Cano Hidalgo
1Instituto Oftalmológico Hospital Conde de Valenciana, México City, Mexico.
Purpose:
To report an alternative treatment for metastatic tumors within the eye.
Case Report:
Five intravitreal injections of bevacizumab (2.5 mg each) were performed in one eye of a 50-year-old woman with choroidal metastasis of lung carcinoma. Tumor size was reduced, pain disappeared, vision improved, and there were no secondary reactions. Vision improved from 20/40 to 20/20 and metamorphopsia decreased. Ten months after initiating treatment, an ultrasonographic study revealed no residual tumor, the choroid was normal in thickness and fluorescein angiography revealed a scar but no mass lesion.
Conclusion:
Intravitreal bevacizumab displayed beneficial effects in reducing tumor size and improving symptoms in this case of choroidal metastasis of lung carcinoma. The antineoplasic properties of this agent make it a viable alternative for treatment of metastatic choroidal tumors.
